Jennifer L. Zachary

2019

In 2019, Jennifer L. Zachary earned a total compensation of $5M as Executive Vice President, General Counsel and Corporate Secretary at Merck & Co., a 3% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$83,704
Non-Equity Incentive Plan$1,529,500
Option Awards$705,120
Salary$856,818
Stock Awards$1,790,006
Other$80,572
Total$5,045,720

Zachary received $1.8M in stock awards, accounting for 35% of the total pay in 2019.

Zachary also received $83.7K of change in pension value and nonqualified deferred compensation earnings, $1.5M in non-equity incentive plan, $705.1K in option awards, $856.8K in salary and $80.6K in other compensation.

Rankings

In 2019, Jennifer L. Zachary's compensation ranked 2,172nd out of 13,971 executives tracked by ExecPay. In other words, Zachary earned more than 84.5% of executives.

ClassificationRankingPercentile
All
2,172
out of 13,971
85th
Division
Manufacturing
789
out of 5,701
86th
Major group
Chemicals And Allied Products
248
out of 2,200
89th
Industry group
Drugs
200
out of 1,886
89th
Industry
Pharmaceutical Preparations
147
out of 1,398
90th

Pay ratio

Jennifer L. Zachary's Pay$5,045,720
Median Employee's Pay$95,621
Pay Ratio

53

to 1

In 2019, the annual total compensation of Jennifer L. Zachary was $5,045,720.

The annual total compensation of the median employee at Merck & Co. was $95,621.

The ratio of Jennifer L. Zachary's pay to the pay of median employee was therefore 53 to one.

Source: SEC filing on April 6, 2020.

Zachary's colleagues

We found four more compensation records of executives who worked with Jennifer L. Zachary at Merck & Co. in 2019.

2019

Kenneth Frazier

Merck & Co.

Chief Executive Officer

2019

Roger Perlmutter

Merck & Co.

M.D., Ph.D. Executive Vice President and President, Merck Research Laboratories

2019

Robert Davis

Merck & Co.

Chief Financial Officer

2019

Sanat Chattopadhyay

Merck & Co.

Executive Vice President and President, Merck Manufacturing Division

News

You may also like